The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease
Open accessAbstract
OBJECTIVE: The aim of this study was to screen for and quantify the neurotoxic amino acid beta-N-methylamino-L-alanine (BMAA) in a cohort of autopsy specimens taken from Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), and non-neurological controls. BMAA is produced by cyanobacteria found in a variety of freshwater, marine, and terrestrial habitats. The possibility of geographically broad human exposure to BMAA had been suggested by the discovery of BMAA in brain tissues of Chamorro patients with ALS/Parkinsonism dementia complex from Guam and more recently in AD patients from North America. These observations warranted an independent study of possible BMAA exposures outside of the Guam ecosystem. METHODS: Postmortem brain specimens were taken from neuropathologically confirmed cases of 13 ALS, 12 AD, 8 HD patients, and 12 age-matched non-neurological controls. BMAA was quantified using a validated fluorescent HPLC method previously used to detect BMAA in patients from Guam. Tandem mass spectrometric (MS) analysis was carried out to confirm the identification of BMAA in neurological specimens. RESULTS: We detected and quantified BMAA in neuroproteins from postmortem brain tissue of patients from the United States who died with sporadic AD and ALS but not HD. Incidental detections observed in two out of the 24 regions were analyzed from the controls. The concentrations of BMAA were below what had been reported previously in Chamarro ALS/ Parkinsonism dementia complex patients, but demonstrated a twofold range across disease and regional brain area comparisons. The presence of BMAA in these patients was confirmed by triple quadrupole liquid chromatography/mass spectrometry/mass spectrometry. CONCLUSIONS: The occurrence of BMAA in North American ALS and AD patients suggests the possibility of a gene/environment interaction, with BMAA triggering neurodegeneration in vulnerable individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mass Spectrometry and Protein Analysis
Domon, B., & Aebersold, R. (2006) · Science · doi:10.1126/science.1124619 · Cited by 2,181
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
Spencer, P. S., Nunn, P. B., Hugon, J., Ludolph, A. C., Ross, S. M., Roy, D. N., & Robertson, R. C. (1987) · Science · doi:10.1126/science.3603037 · Cited by 897
Diverse taxa of cyanobacteria produce β- N -methylamino- l -alanine, a neurotoxic amino acid
Cox, P. A., Banack, S. A., Murch, S. J., Rasmussen, U., Tien, G., Bidigare, R. R., Metcalf, J. S., Morrison, L. F., Codd, G. A., & Bergman, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501526102 · Cited by 707
Self-citationCox, P. A., Banack, S. A., & Murch, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235808100 · Cited by 633
Self-citationHydrolysis and amino acid composition analysis of proteins
Fountoulakis, M., & Lahm, H.-W. (1998) · Journal of Chromatography A · doi:10.1016/s0021-9673(98)00721-3 · Cited by 606
Murch, S. J., Cox, P. A., & Banack, S. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404926101 · Cited by 416
Self-citationOccurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam
Murch, S. J., Cox, P. A., Banack, S. A., Steele, J. C., & Sacks, O. W. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00320.x · Cited by 346
Self-citationCycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam
Cox, P. A., & Sacks, O. W. (2002) · Neurology · doi:10.1212/wnl.58.6.956 · Cited by 329
Self-citationBMAA selectively injures motor neurons via AMPA/kainate receptor activation
Rao, S. D., Banack, S. A., Cox, P. A., & Weiss, J. H. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.04.017 · Cited by 279
Self-citation
Cited by
Tau and neurodegenerative disease: the story so far
Iqbal, K., Liu, F., & Gong, C.-X. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.225 · Cited by 806
Heintz‐Buschart, A., Pandey, U., Wicke, T., Sixel‐Döring, F., Janzen, A., Sittig‐Wiegand, E., Trenkwalder, C., Oertel, W. H., Mollenhauer, B., & Wilmes, P. (2018) · Movement Disorders · doi:10.1002/mds.27105 · Cited by 554
Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease
Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., & Battino, M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw023 · Cited by 496
Risk factors for amyotrophic lateral sclerosis
Fang, F., Ingre, C., Roos, P., Kamel, F., & Piehl, F. (2015) · Clinical Epidemiology · doi:10.2147/clep.s37505 · Cited by 462
Dunlop, R. A., Cox, P. A., Banack, S. A., & Rodgers, K. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075376 · Cited by 314
Self-citation
Metadata
- Authors
- Pablo, J., Banack, S. A., Cox, P. A., Johnson, T. E., Papapetropoulos, S., Bradley, W. G., Buck, A., & Mash, D. C.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Hindawi Limited
- Published
- 2009-10
- Volume
- 120
- Issue
- 4
- Pages
- 216-225
- ISSN
- 0001-6314 (ISSN-L)
- 1600-0404
- OpenAlex
- W1970484692
- Cited by
- 333
- References
- 25
- FWCI
- 12.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease. https://app.cochat.ai/papers/10.1111/j.1600-0404.2008.01150.x
- The paper
- Pablo, J., Banack, S. A., Cox, P. A., Johnson, T. E., Papapetropoulos, S., Bradley, W. G., Buck, A., & Mash, D. C. (2009). Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.2008.01150.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.